Literature DB >> 32506942

Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.

David C Klonoff1.   

Abstract

Entities:  

Keywords:  COVID-19; HIPAA; diabetes; privacy; telemedicine

Mesh：

Year:  2020        PMID： 32506942      PMCID： PMC7673185          DOI： 10.1177/1932296820932958

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  1 in total

1.  International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission.

Authors:  Janet L Davidson; Mary L Johnson; Gregg D Simonson; Amy B Criego; Thomas W Martens; Anders L Carlson; Richard M Bergenstal
Journal:  J Diabetes Sci Technol       Date:  2020-05-14
  1 in total
  7 in total

1.  Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.

Authors:  David C Klonoff; Jennifer Y Zhang; Trisha Shang; Chhavi Mehta; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2020-12-08

2.  How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.

Authors:  Jennifer Y Zhang; Trisha Shang; David Ahn; Kong Chen; Gerard Coté; Juan Espinoza; Carlos E Mendez; Elias K Spanakis; Bithika Thompson; Amisha Wallia; Lauren E Wisk; David Kerr; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-01-21

Review 3.  Pedagogy and innovative care tenets in COVID-19 pandemic: An enhancive way through Dentistry 4.0.

Authors:  Mohd Javaid; Abid Haleem; Ravi Pratap Singh; Rajiv Suman
Journal:  Sens Int       Date:  2021-07-24

4.  Evaluating the usability and safety of the semaglutide single-dose pen-injectors through summative (human factors) usability testing.

Authors:  David C Klonoff; Stephanie Bassock; Andrea Dwyer; Ella Engels; Marianne Qvist; Thomas Sparre; Soren Snitker
Journal:  J Diabetes Investig       Date:  2020-11-18       Impact factor: 4.232

5.  Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown.

Authors:  Federico Boscari; Sara Ferretto; Ambra Uliana; Angelo Avogaro; Daniela Bruttomesso
Journal:  Nutr Diabetes       Date:  2021-01-05       Impact factor: 5.097

6.  Contents and sentiment analysis of newspaper articles and comments on telemedicine in Korea: Before and after of COVID-19 outbreak.

Authors:  EunKyo Kang; Narae Song; HyoRim Ju
Journal:  Health Informatics J       Date:  2022 Jan-Mar       Impact factor: 2.681

7.  Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.

Authors:  Yukiko Onishi; Yoko Yoshida; Toshiko Takao; Tazu Tahara; Takako Kikuchi; Toshiko Kobori; Tetsuya Kubota; Asuka Shimmei; Masahiko Iwamoto; Masato Kasuga
Journal:  J Diabetes Investig       Date:  2021-04-08       Impact factor: 3.681
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.